Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Soria

Showing results (61-70 of 587) with videos related to

Pageof 59
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2021
Building bridges between drug development and cancer science: a tribute to José Baselga's legacyD M Hyman, J-C Soria, J Tabernero
Journal of Chromatography. A|June 15, 2007
Estimation of recovery by multistep purge-and-trap gas chromatographic-mass spectrometric analysis of honey volatilesA C Soria, I Martínez-Castro, J Sanz
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Molecular targeting: targeting angiogenesis in solid tumorsJ-C Soria, J Fayette, J-P Armand
Bailliere'S Clinical Haematology|September 1, 1993
Endothelial cell proteases: physiological role and regulationS Menashi, H Lu, C Soria, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|November 1, 1983
[Heparinization of extracorporeal shunts]B Touchot, J Soria, C Soria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?J C Soria, C Massard, T Le Chevalier
Bulletin Du Cancer|December 26, 2009
[Targeting KRAS pathway in NSCLC therapy]S Le Moulec, Y Loriot, J-C Soria
Medicina Cutanea Ibero-Latino-Americana|January 1, 1990
[Acquired bullous epidermolysis and multiple myeloma]C Soria, E Muñoz, A España, et al.
Revista Clinica Espanola|May 1, 1990
[Crohn disease metastatic to the skin]C Soria, M Aguado, E Muñoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapyB Besse, J C Soria, T Le Chevalier
Pageof 59

Showing results (61-70 of 587) with videos related to

Sort By:
Pageof 59
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2021
Building bridges between drug development and cancer science: a tribute to José Baselga's legacyD M Hyman, J-C Soria, J Tabernero
Journal of Chromatography. A|June 15, 2007
Estimation of recovery by multistep purge-and-trap gas chromatographic-mass spectrometric analysis of honey volatilesA C Soria, I Martínez-Castro, J Sanz
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Molecular targeting: targeting angiogenesis in solid tumorsJ-C Soria, J Fayette, J-P Armand
Bailliere'S Clinical Haematology|September 1, 1993
Endothelial cell proteases: physiological role and regulationS Menashi, H Lu, C Soria, et al.
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|November 1, 1983
[Heparinization of extracorporeal shunts]B Touchot, J Soria, C Soria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?J C Soria, C Massard, T Le Chevalier
Bulletin Du Cancer|December 26, 2009
[Targeting KRAS pathway in NSCLC therapy]S Le Moulec, Y Loriot, J-C Soria
Medicina Cutanea Ibero-Latino-Americana|January 1, 1990
[Acquired bullous epidermolysis and multiple myeloma]C Soria, E Muñoz, A España, et al.
Revista Clinica Espanola|May 1, 1990
[Crohn disease metastatic to the skin]C Soria, M Aguado, E Muñoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2005
Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapyB Besse, J C Soria, T Le Chevalier
Pageof 59